Letter: is tenofovir superior to entecavir for hepatocellular carcinoma prevention in chronic hepatitis B?

Aliment Pharmacol Ther. 2020 Jan;51(2):314-315. doi: 10.1111/apt.15603.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Carcinoma, Hepatocellular*
  • Guanine / analogs & derivatives
  • Hepatitis B virus
  • Hepatitis B, Chronic*
  • Hepatitis D*
  • Humans
  • Liver Cirrhosis
  • Liver Neoplasms*
  • Tenofovir
  • Virus Replication

Substances

  • entecavir
  • Guanine
  • Tenofovir